NEW YORK – Biocept reported after the close of the market on Wednesday that its first quarter revenues rose 41 percent year over year, driven by a 27 percent increase in revenue per commercial accession.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.